Please check your internet connection and try again.
# Methycobalime (methylcobalamin)
## Overview
Methycobalime, containing methylcobalamin, is an active, coenzyme form of vitamin B12. It is essential for DNA synthesis, red blood cell formation, and neurological function.
## Primary Indications
* Vitamin B12 deficiency anemia
* Peripheral neuropathy (e.g., diabetic neuropathy, carpal tunnel syndrome) - efficacy for this indication is debated and not universally established.
* Adjunctive therapy in certain megaloblastic anemias.
## Adult Dosing
* **Vitamin B12 Deficiency Anemia:** Typically 1000 mcg (1 mg) intramuscularly or subcutaneously once daily for a week, followed by 1000 mcg (1 mg) intramuscularly or subcutaneously once weekly for a month, then 1000 mcg (1 mg) intramuscularly or subcutaneously once monthly for maintenance. Oral formulations may be used, but parenteral administration is generally preferred for initial correction of severe deficiency. Specific oral dosing varies widely and depends on the formulation and formulation manufacturer's recommendations.
* **Peripheral Neuropathy:** Dosing varies. Common regimens include oral methylcobalamin 500 mcg to 1500 mcg daily. Parenteral dosing can range from 1000 mcg IM/SC every other day to weekly. Consult local protocols for established guidelines.
## Pediatric Dosing
Established pediatric dosing for methylcobalamin is not widely standardized. Dosing for vitamin B12 deficiency in children typically follows adult principles but requires careful titration based on age, weight, and severity of deficiency. Consult pediatric hematology guidelines.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as methylcobalamin is an endogenous substance. However, the underlying cause of the deficiency (e.g., malabsorption) may necessitate ongoing treatment or further investigation.
## Contraindications
* Hypersensitivity to cobalamin or any component of the formulation.
## Adverse Effects
Generally well-tolerated.
* **Common:** Nausea, vomiting, diarrhea, headache, rash, pruritus, injection site reactions (pain, redness, swelling).
* **Rare:** Anaphylaxis, pulmonary edema, congestive heart failure (associated with rapid repletion in severely deficient individuals).
## Key Drug Interactions
* **Chloramphenicol:** May interfere with the hematopoietic response to vitamin B12.
* **Proton Pump Inhibitors (PPIs) and H2 Receptor Antagonists:** May decrease absorption of oral vitamin B12 over long-term use.
* **Metformin:** May interfere with vitamin B12 absorption.
## Monitoring
* **Hemoglobin and Hematocrit:** To assess response in anemia.
* **Reticulocyte count:** To assess bone marrow response.
* **Vitamin B12 levels:** To confirm deficiency and monitor repletion.
* **Neurological status:** To assess improvement in neuropathy symptoms.
## Clinical Pearls
* Parenteral administration bypasses potential malabsorption issues common with oral vitamin B12.
* Monitoring for signs of hypokalemia is important during initial repletion of severe B12 deficiency due to rapid cell proliferation.
* The efficacy of methylcobalamin for peripheral neuropathy in the absence of documented B12 deficiency is controversial.
**Disclaimer:** This information is intended for clinical professionals. Always verify current prescribing information and local protocols before making clinical decisions.
